- Home
- CRDL vs CFSB Comparison
CRDL vs CFSB Comparison
Compare CRDL & CFSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDL
- CFSB
- Stock Information
- Founded
- CRDL 2017
- CFSB 1889
- Country
- CRDL Canada
- CFSB United States
- Employees
- CRDL N/A
- CFSB N/A
- Industry
- CRDL Biotechnology: Biological Products (No Diagnostic Substances)
- CFSB Major Banks
- Sector
- CRDL Health Care
- CFSB Finance
- Exchange
- CRDL Nasdaq
- CFSB Nasdaq
- Market Cap
- CRDL 90.4M
- CFSB 92.5M
- IPO Year
- CRDL N/A
- CFSB N/A
- Fundamental
- Price
- CRDL $1.22
- CFSB $14.23
- Analyst Decision
- CRDL Strong Buy
- CFSB
- Analyst Count
- CRDL 2
- CFSB 0
- Target Price
- CRDL $9.00
- CFSB N/A
- AVG Volume (30 Days)
- CRDL 859.1K
- CFSB 10.7K
- Earning Date
- CRDL 11-13-2025
- CFSB 10-29-2025
- Dividend Yield
- CRDL N/A
- CFSB N/A
- EPS Growth
- CRDL N/A
- CFSB N/A
- EPS
- CRDL N/A
- CFSB N/A
- Revenue
- CRDL N/A
- CFSB $7,612,000.00
- Revenue This Year
- CRDL N/A
- CFSB N/A
- Revenue Next Year
- CRDL N/A
- CFSB N/A
- P/E Ratio
- CRDL N/A
- CFSB N/A
- Revenue Growth
- CRDL N/A
- CFSB N/A
- 52 Week Low
- CRDL $0.77
- CFSB $6.41
- 52 Week High
- CRDL $2.24
- CFSB $14.24
- Technical
- Relative Strength Index (RSI)
- CRDL 63.48
- CFSB 61.63
- Support Level
- CRDL $1.01
- CFSB $13.93
- Resistance Level
- CRDL $1.38
- CFSB $14.24
- Average True Range (ATR)
- CRDL 0.08
- CFSB 0.04
- MACD
- CRDL 0.02
- CFSB -0.00
- Stochastic Oscillator
- CRDL 58.60
- CFSB 96.83
About CRDL Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.
About CFSB CFSB Bancorp Inc.
CFSB Bancorp Inc provides banking services. It offers a variety of financial services to individuals and small businesses through its offices in Quincy, Holbrook, and Weymouth. Its primary deposit products are savings, checking, and term certificate accounts, and its primary lending product is residential mortgage loans.The Company's loan portfolio includes residential real estate, commercial real estate, construction, and consumer loan segments. Residential real estate loans include classes for one- to four-family, multi-family, second mortgages and home equity lines of credit.